Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.7990
-0.0120 (-1.48%)
At close: Jun 27, 2025, 4:00 PM
0.7850
-0.0140 (-1.75%)
After-hours: Jun 27, 2025, 7:51 PM EDT
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $6.72 million as of June 27, 2025. Its market cap has decreased by -84.09% in one year.
Market Cap
6.72M
Enterprise Value
10.03M
1-Year Change
-84.09%
Ranking
Category
Stock Price
0.80
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $6.72M, a decrease of -95.47%. That is a compound annual growth rate of -52.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 6.90M | 114.14% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |